Author:
Zou Xiaohui,Chang Kang,Fan Guohui,Zheng Huanwei,Shen Hezheng,Tang Liang,Yang Yingying,Wang Yeming,Zhao Linhua,Lv Hong,Zhou Xin,Shen Xiaoming,Chen Liqiang,Tong Xiaolin,Cao Bin
Reference35 articles.
1. WHO. Who coronavirus (COVID-19) dashboard. 2023, 2023(Sep, 4th): https://covid19.who.int.
2. Characteristics of SARS-CoV-2 and COVID-19;Hu;Nat Rev Microbiol,2021
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan;Huang;China Lancet,2020
4. US Food and Drug Administration. Assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biological products for COVID-19 prevention or treatment guidance for industry. Guidance for industry, September, 2020.
5. An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy;Pillaiyar;J Med Chem,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献